The role of cellular senescence and SASP in tumour microenvironment
- PMID: 35106956
- DOI: 10.1111/febs.16381
The role of cellular senescence and SASP in tumour microenvironment
Abstract
Cellular senescence refers to a state of irreversible cell cycle arrest that can be induced by various cellular stresses and is known to play a pivotal role in tumour suppression. While senescence-associated growth arrest can inhibit the proliferation of cancer-prone cells, the altered secretory profile of senescent cells, termed the senescence-associated secretory phenotype, can contribute to the microenvironment that promotes tumour development. Although the senescence-associated secretory phenotype and its effects on tumorigenesis are both highly context dependent, mechanisms underlying such diversity are becoming better understood, thereby allowing the creation of new strategies to effectively target the senescence-associated secretory phenotype and senescent cells for cancer therapy. In this review, we discuss the current knowledge on cellular senescence and the senescence-associated secretory phenotype to develop a structural understanding of their roles in the tumour microenvironment and provide perspectives for future research, including the possibility of senotherapy for the treatment of cancer.
Keywords: SASP; senescence surveillance; senolytics; senomorphics; tumour microenvironment.
© 2022 Federation of European Biochemical Societies.
Similar articles
-
Cellular senescence and the tumour microenvironment.Mol Oncol. 2022 Sep;16(18):3333-3351. doi: 10.1002/1878-0261.13268. Epub 2022 Jun 26. Mol Oncol. 2022. PMID: 35674109 Free PMC article. Review.
-
Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.Mol Oncol. 2021 Dec;15(12):3242-3255. doi: 10.1002/1878-0261.13042. Epub 2021 Jul 12. Mol Oncol. 2021. PMID: 34137158 Free PMC article. Review.
-
Senescent cells in cancer therapy: why and how to remove them.Cancer Lett. 2021 Nov 1;520:68-79. doi: 10.1016/j.canlet.2021.07.002. Epub 2021 Jul 5. Cancer Lett. 2021. PMID: 34237406 Review.
-
Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.Adv Protein Chem Struct Biol. 2023;133:115-158. doi: 10.1016/bs.apcsb.2022.10.002. Epub 2022 Nov 25. Adv Protein Chem Struct Biol. 2023. PMID: 36707199 Review.
-
Effects of senescence on the tumour microenvironment and response to therapy.FEBS J. 2024 Jun;291(11):2306-2319. doi: 10.1111/febs.16984. Epub 2023 Nov 1. FEBS J. 2024. PMID: 37873605 Review.
Cited by
-
Targeting immunosenescence for improved tumor immunotherapy.MedComm (2020). 2024 Oct 28;5(11):e777. doi: 10.1002/mco2.777. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39473905 Free PMC article. Review.
-
Immune therapeutic strategies for the senescent tumor microenvironment.Br J Cancer. 2024 Oct 28. doi: 10.1038/s41416-024-02865-7. Online ahead of print. Br J Cancer. 2024. PMID: 39468331 Review.
-
Senescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients.Cells. 2024 Sep 26;13(19):1613. doi: 10.3390/cells13191613. Cells. 2024. PMID: 39404377 Free PMC article.
-
Inflammation-Associated Stem Cells in Gastrointestinal Cancers: Their Utility as Prognostic Biomarkers and Therapeutic Targets.Cancers (Basel). 2024 Sep 12;16(18):3134. doi: 10.3390/cancers16183134. Cancers (Basel). 2024. PMID: 39335106 Free PMC article. Review.
-
Novel Arf1 Inhibitors Drive Cancer Stem Cell Aging and Potentiate Anti-Tumor Immunity.Adv Sci (Weinh). 2024 Oct;11(39):e2404442. doi: 10.1002/advs.202404442. Epub 2024 Sep 3. Adv Sci (Weinh). 2024. PMID: 39225354 Free PMC article.
References
-
- Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729-40.
-
- Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci. 2011;124:68-81.
-
- Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-7.
-
- Freund A, Laberge RM, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell. 2012;23:2066-75.
-
- Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853-68.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources